Literature DB >> 16889750

Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis.

Eun Ha Shin1, Ha Young Lee, Yoe-Sik Bae.   

Abstract

Although leukotriene B4 (LTB4) has been reported to stimulate monocytes and neutrophils, its role on dendritic cell (DC) activity has not been examined. Here, we investigated the expression of LTB4 receptor and the effect of LTB4 on human DC chemotaxis. We analyzed LTB4 receptors, BLT1 and BLT2, by using RT-PCR. DCs express BLT2 but not BLT1 mRNA. DCs were chemotactically migrated to LTB4. LTB4-induced DC chemotaxis was completely inhibited by pertussis toxin, indicating the role of Gi proteins. LTB4 induced mitogen activated protein kinase activation and Akt activation. LTB4-induced DC chemotaxis was mediated by extracellular signal-regulated protein kinase and phosphoinositide 3-kinase but not by p38 kinase. BLT2-selevite antagonist, LY255283, almost completely inhibited DC chemotaxis induced by LTB4 but not by Trp-Lys-Tyr-Met-Val-D-Met. Thus human myeloid DCs express functional BLT2 but not BLT1, suggesting a physiological role of LTB4 and BLT2 in regulating DC trafficking during induction of immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889750     DOI: 10.1016/j.bbrc.2006.07.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Selective inhibition of leukotriene receptor BLT-2 reduces vascular oxidative stress and improves endothelial function in ApoE-/- mice.

Authors:  Friedrich Felix Hoyer; Lisa Albrecht; Georg Nickenig; Cornelius Müller
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

2.  Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema.

Authors:  Eliseu O De Oliveira; Kan Wang; Hye-Sik Kong; Suhyon Kim; Matthew Miessau; Robert J Snelgrove; Y Michael Shim; Mikell Paige
Journal:  Bioorg Med Chem Lett       Date:  2011-09-20       Impact factor: 2.823

Review 3.  The role of the LTB4-BLT1 axis in chemotactic gradient sensing and directed leukocyte migration.

Authors:  Bhagawat C Subramanian; Ritankar Majumdar; Carole A Parent
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

Review 4.  Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking.

Authors:  J Hoggatt; L M Pelus
Journal:  Leukemia       Date:  2010-09-30       Impact factor: 11.528

5.  Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function.

Authors:  Jens Dannull; Tristan Schneider; Walter T Lee; Nicole de Rosa; Douglas S Tyler; Scott K Pruitt
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

Review 6.  Eicosanoids and cancer.

Authors:  Dingzhi Wang; Raymond N Dubois
Journal:  Nat Rev Cancer       Date:  2010-02-19       Impact factor: 60.716

7.  Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Authors:  B J R Whittle; C Varga; A Berko; K Horvath; A Posa; J P Riley; K A Lundeen; A M Fourie; P J Dunford
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

8.  Activity of the leukotriene pathway in Barrett's metaplasia and oesophageal adenocarcinoma.

Authors:  James David Shutt; Philip Boger; James Richard Neale; Praful Patel; Anthony Peter Sampson
Journal:  Inflamm Res       Date:  2012-08-01       Impact factor: 4.575

Review 9.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

10.  Key role of group v secreted phospholipase A2 in Th2 cytokine and dendritic cell-driven airway hyperresponsiveness and remodeling.

Authors:  William R Henderson; Xin Ye; Ying Lai; Zhanglin Ni; James G Bollinger; Ying-Tzang Tien; Emil Y Chi; Michael H Gelb
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.